China stocks slump as Huawei shakes sentiment, drugmakers plunge | Fin24
  • Covid-19 Money Hub

    The hub will help answer your business and money questions during the coronavirus crisis.

  • Dudu Myeni

    The former SAA chair has been declared a delinquent director for her role at the national airline.

  • Cigarette Ban

    Govt says emerging research shows smoking leads to more severe cases of Covid-19.


China stocks slump as Huawei shakes sentiment, drugmakers plunge

Dec 06 2018 14:35
Kana Nishizawa, Bloomberg

A gauge of Chinese stocks in Hong Kong headed for its biggest two-day drop in 10 months as the arrest of Huawei Technologies' chief financial officer dealt fragile investor sentiment another blow and deepened uncertainty over China’s relations with the US.

The Hang Seng China Enterprises Index dropped 2.9% as of 15:00, while the Shanghai Composite Index fell 1.7%. Technology stocks were among the hardest hit in both markets as Huawei suppliers tumbled. Huawei CFO Wanzhou Meng is facing extradition to the US after her arrest in Vancouver in connection with potential violations by the company of American sanctions on Iran, according to Canada’s Department of Justice. Drugmakers tumbled amid concern over price cuts, while the yuan fell for a second day.

"The news on Huawei comes at a bad time when investor sentiment is weak" and when there’s lack of reasons to buy the market toward year-end, said Toshihiko Takamoto, a Singapore-based money manager at Asset Management One. "The consensus is that this trade war may drag on for 10 years."

Chinese drug stocks headed for their worst drop since 2009 as investors worried the government is driving down prices for their products via a centralized procurement program. The MSCI China Health Care Index plunged 7.8%, with Sino Biopharmaceutical sliding 14%. CSPC Pharmaceutical Group and Genscript Biotech lost more than 11%.

The Hang Seng China measure was headed for a two-day decline of 4.2%. Hong Kong’s benchmark Hang Seng Index retreated 2.7% on Thursday, with AAC Technologies Holdings and Huawei supplier Sunny Optical Technology Group declining more than 5.8%. ZTE slid at least 5.6% in Hong Kong and in Shenzhen.

The news on the Chinese tech giant adds to investor skepticism over the progress of China-US trade relations. While selling pressure eased on Wednesday following China’s pledge to move quickly on US trade commitments, doubts remain over whether there’s been any real breakthrough. When concern flared in November that the US was ramping up a campaign against Huawei, the Shanghai Composite Index slumped, with technology shares heavily hit.

* Sign up to Fin24's top news in your inbox: SUBSCRIBE TO FIN24 NEWSLETTER

equities  |  markets  |  currencies


Company Snapshot

Voting Booth

How has Covid-19 impacted your financial position?

Previous results · Suggest a vote